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a  b  s  t  r  a  c  t
Innate  immunity  pathways  constitute  the  ﬁrst line  of defense  against  infections  and  cellular  damage.  An
emerging  concept  in  these  pathways  is that  signaling  involves  the  formation  of  ﬁnite  (e.g.  rings  in  NLRs)
or  open-ended  higher-order  assemblies  (e.g.  ﬁlamentous  assemblies  by members  of the  death-fold  family
and TIR  domains).  This  signaling  by cooperative  assembly  formation  (SCAF)  mechanism  allows  rapid  and
strongly  ampliﬁed  responses  to minute  amounts  of stimulus.  While  the  characterization  of  the  molecular
mechanisms  of  SCAF  has  seen  rapid  progress,  little  is  known  about its regulation.  One  emerging  theme
involves  proteins  produced  both  in host  cells  and  by pathogens  that  appear  to  mimic  the  signaling  com-
ponents.  Recently  characterized  examples  involve  the  capping  of  the  ﬁlamentous  assemblies  formed  by
caspase-1  CARDs  by  the CARD-only  protein  INCA,  and  those  formed  by  caspase-8  by the  DED-containingomain, leucine-rich
epeat-containing/nucleotide and
ligomerization domain-like receptor (NLR)
IG-I-like receptor (RLR)
ignaling by cooperative assembly
ormation (SCAF)
protein  MC159.  By  contrast,  the CARD-only  protein  ICEBERG  and  the  DED-containing  protein  cFLIP  incor-
porate  into  signaling  ﬁlaments  and presumably  interfere  with  proximity  based  activation  of caspases.  We
review  selected  examples  of  SCAF  in innate  immunity  pathways  and  focus  on  the  current  knowledge  on
signaling  component  mimics  produced  by mammalian  and  pathogen  cells and  what  is known  about  their
mechanisms  of  action.
© 2018  Elsevier  Ltd. All  rights  reserved.
oll-like receptor (TLR)
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e. Innate immunity and signaling by cooperative assembly
ormation (SCAF)
The innate immune system functions as a ﬁrst line of defense
gainst infections and cellular damage, detecting pathogens and
ellular perturbations via recognition of evolutionarily conserved
athogen-associated molecular patterns (PAMPs) and danger-
ssociated molecular patterns (DAMPs) by pattern-recognition
eceptors (PRRs). The PRRs of the mammalian innate immune sys-
em include the membrane-associated TLRs (Toll-like receptors)
nd CLRs (C-type lectin domain receptors), and the cytoplas-
ic  NLRs (NOD [nucleotide binding and oligomerization domain],
eucine-rich repeat-containing receptors), PYHIN (pyrin and HIN
hematopoietic interferon-inducible nuclear localization 200]
mino acid repeat domain containing family) proteins, the RLRs
RIG-I [retinoic acid-inducible gene 1]-like receptors), the OAS pro-
eins (nucleic acid-sensing oligoadenylate synthase family), and
he cGAS proteins (OAS homologue cyclic GMP–AMP [cGAMP] syn-
hase). Activation of these PRRs by binding of PAMPs (such as
ipopolysaccharide, bacterial ﬂagellin, and foreign nucleic acids),
r DAMPs (such as extracellular ATP, potassium efﬂux, uric acid
rystals, ionophores, and reactive oxygen species), triggers a sig-
aling cascade that induces upregulation of cytokine expression,
rocessing of pro-inﬂammatory cytokines, and programmed cell-
eath responses.
A common feature of many innate immunity signaling pathways
s the formation of higher-order signaling complexes, resulting in
signaling by cooperative assembly formation’ (SCAF) [1–7] (Fig. 1).
ith SCAF, PRRs oligomerize and nucleate the recruitment and
ligomerization of downstream adaptor proteins and eventually
ffector enzymes, with oligomerization of upstream components
eeding and facilitating the oligomerization of downstream compo-
ents. The higher-order assemblies can either be ﬁnite (for example
ings in NLRs [8,9]), or open-ended assemblies (for example ﬁla-
ents of the adaptor ASC (apoptosis-associated speck-like protein
ontaining a caspase recruitment domain) [10]). SCAF has been
bserved in inﬂammasome signaling, initiated by activated NLRs
nd PYHIN receptors, and in RLR and TLR signaling [10–14]. Sig-
alosomes of the innate immune system largely form through
omotypic interactions between TIR (Toll/interleukin-1 receptor)
omains [15], or between the members of the death-fold family,
ncluding the pyrin domain (PYD), caspase activation and recruit-
ent domain (CARD), death effector domain (DED), and death
omain (DD) [16]. TIR domains and the death-fold domains are
tructurally distinct; the former generally feature a central ﬁve-
tranded parallel -sheet (strands A–E) surrounded by ﬁvePlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
-helices (A–E), whereas the latter contain six -helices in an
nti-parallel arrangement.
Aspects of SCAF, such as co-localization and proximity-induced
nzyme activation, are well recognized characteristics of ‘classi-cal’ signaling pathways (see [17,18] for examples). However, SCAF
takes advantage of these mechanisms as central features that facil-
itate a rapid immune response to a low-level stimulus. While
higher-order assemblies are not limited to innate immunity path-
ways [19,20,21], this mechanism is ideally suited to signaling in
these pathways.
The molecular mechanisms of SCAF have been characterized
now in several systems, and a number of recent reviews summa-
rize these advances [1–7]. What is at a much earlier stage is the
understanding of the regulation of assembly mechanisms in the cell
and the disassembly of signalosomes, which at least in some cases
would be predicted to form in a reversible fashion. In this review,
we address the topic of regulation of SCAF in innate immunity path-
ways. Many well-established regulatory mechanisms can modulate
assembly formation, from processes that affect the concentrations
of components in the cell to post-translational modiﬁcations, such
as phosphorylation of RIG-I and MDA5 (melanoma differentia-
tion associated factor 5) CARDs [22] and glutathionylation of the
MAL  TIR domain [23]. We  focus on the modulation of assembly
formation by assembly component mimics or decoys that inhibit
signalosome formation and signaling outputs; many such proteins
originate from pathogens that aim to suppress immune responses.
We ﬁrst describe the SCAF mechanisms in four selected systems
(inﬂammasomes, RLRs, TLRs and necrosomes) and then discuss the
current knowledge of the mechanisms regulating SCAF in the cor-
responding pathways through molecular mimics.
1.1. Inﬂammasome assembly
In the case of inﬂammasomes, the assembly process generally
consists of ligand-induced activation and oligomerization of a PRR
(NLR or PYHIN family member), with subsequent recruitment and
oligomerization of the adaptor protein ASC through interactions
of either its N-terminal PYD or C-terminal CARD, with PYDs or
CARDs of the PRR [10]. The recruited ASC forms helical ﬁlaments
through PYD:PYD interactions, and in turn recruits procaspases
and nucleates the formation of procaspase ﬁlaments through
either CARD:CARD interactions, as in the case of procaspase-1, or
PYD:DED interactions, as in the case of procaspase-8 [10,13,24,25].
The clustering of procaspases induces proximity-based autoprote-
olytic maturation of procaspases into active caspases, which are
then able to process pro-inﬂammatory cytokines, such as inter-
leukin (IL)-1 and IL-18, cleave gasdermin D to initiate pyroptosis,
or, in the case of ASC-based activation of caspase-8, initiate apo-
ptosis [25].naling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
1.1.1. Nucleation of AIM2 inﬂammasome assemblies
The PYHIN family members found in humans include AIM2
(absent in melanoma 2), IFI16 (interferon gamma inducible pro-
tein 16), IFIX (interferon inducible protein X), and MNDA (myeloid
ARTICLE IN PRESSG ModelYSCDB-2575; No. of Pages 19
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Fig. 1. Signaling by cooperative assembly formation (SCAF) and its negative regulation by molecular mimics. (Left) With SCAF, after the ligand (L, blue) binds to the receptor, the
activated receptor initiates signal transduction through higher-order assembly formation, which involves cooperative interactions with adaptor proteins (A) and eventually
e ctivat
i n of S
b le wit
r
n
a
t

d
P
i
b
d
t
p
a
s
o
t
r
b
b
d
t
s
p
P
a
w
d
t
f
t
d
t
A
d
a
a
t
e
o
P
t
a
iffector enzymes (E) to form a signalosome. The large assembly can lead to rapid a
nactive and activated proteins, respectively. (Right) Example of negative regulatio
ind  to the assembly, but because some of its interaction interfaces are incompatib
esponse is reduced.
uclear differentiation antigen). Members of the PYHIN family
re deﬁned by the presence of an N-terminal PYD, and one or
wo copies of a C-terminal HIN domain. The latter domain has a
-barrel oligonucleotide/oligosaccharide binding (OB) fold; these
omains mediate the binding of double-stranded (ds) DNA. Of the
YHIN family members, AIM2 and IFI16 have been reported to form
nﬂammasomes, with AIM2 inﬂammasome formation being the
est characterized [26,27].
The crystal structure of the AIM2 HIN domain in complex with
sDNA revealed that the OB folds of the HIN domain stack one above
he other along dsDNA, with the OB folds and the linker region
roviding a concave surface consisting of predominantly basic
mino acid residues, to interact with the negatively charged dsDNA
ugar-phosphate backbone. The AIM2 HIN domains themselves
ligomerize along dsDNA in a head-to-tail arrangement [27]. Fur-
hermore, AIM2 has been proposed to reside in an auto-inhibited
esting state within the cytosol, due to electrostatic interactions
etween an acidic patch on the PYD and the HIN domain dsDNA
inding site; these interactions are displaced by binding of the HIN
omain to dsDNA, liberating the PYD for association with ASC.
AIM2 PYD and HIN domains were shown to form a complex
hat could be disrupted by either the presence of dsDNA or the
ubstitution of acidic residues in the AIM2 PYD domain, based on a
ull-down assay with maltose-binding protein (MBP)-tagged AIM2
YD [27]. The AIM2 HIN domain was also reported to display greater
fﬁnity for dsDNA than full-length AIM2 [27]. However, recent
ork has reported that full-length AIM2 has greater afﬁnity for
sDNA than the AIM2 HIN domain [28]. The MBP-tag was  found
o interfere with the dsDNA binding and oligomerization of both
ull-length AIM2 and the AIM2 HIN domain. Furthermore, muta-
ion of residues within the AIM2 PYD “acidic patch” impaired AIM2
sDNA binding rather than enhancing afﬁnity. These results dispute
he proposed auto-inhibitory mechanism [28].
Electron microscopy studies of AIM2 demonstrate that in vitro,
IM2 can self-assemble into helical ﬁlaments in the absence of
sDNA, with the AIM2 PYD forming the helical core of the ﬁlament
nd the AIM2 HIN domains clustered on the periphery of the ﬁl-
ment [28,29]. The in vivo concentration of AIM2 was  suggested
o remain too low to seed ﬁlament formation [28]. In the pres-
nce of foreign dsDNA, on the other hand, the AIM2 HIN domains
ligomerize along dsDNA, forming a hexamer, causing the AIM2Please cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
YD to cluster and assemble into short helical ﬁlaments [28]. Elec-
ron microscopy suggests the AIM2 PYD ﬁlament forms a helical
ssembly similar to other death-fold domain assemblies, consist-
ng of six surrounding protein surfaces, which mediate three typesion of effector enzymes by proximity-induced activation. Red and green represent
CAF through capping the assembly by the adaptor A2-mimic (I). The inhibitor can
h further assembly formation, the assembly formation is stopped and the signaling
of interfaces (type I, II, and III). Upon clustering of the AIM2 PYD
and assembly into short helical ﬁlaments, the AIM2 PYD ﬁlament
is thought to act as a template for the recruitment of ASC PYD,
and induce formation of ASC PYD assemblies in a mechanism sim-
ilar to that reported for RIG-I/MDA5:MAVS assemblies (see below)
[28,29].
1.1.2. Nucleation of NLR inﬂammasome assemblies
Members of the NLR family share a central NOD, which is
common to all NLRs, and typically contain a C-terminal LRR and
variable N-terminal domains. There are three types of NLRs based
on their N-terminal domains: NLRPs, NLRCs and NLRBs or NAIPs
(NLR family, apoptosis inhibitory protein), containing N-terminal
PYD, CARD and BIR (baculovirus inhibitor of apoptosis protein
repeat) domains, respectively [30].
The only NLR family members conclusively shown to induce
inﬂammasome assembly are NLRP1, NLRP3, and NLRC4. NLRP6, 7,
and 12 may  also form inﬂammasomes; however, these pathways
are less-well characterized [31,32]. While recombinant NLRP1 has
been shown to form an oligomeric ring structure in vitro [33], there
is little detail regarding the structure and mechanism of NLRP-
type NLRs. The crystal structure of mouse NLRC4 without the CARD
(mNLRC4CARD) suggests that NLRC4 is maintained in an auto-
inhibited monomeric state by the C-terminal LRR domain, which
is contorted to contact the NOD, preventing oligomerization [34].
The single NAIP receptor in humans detects bacterial ﬂagellin and
needle subunits of the type 3 secretion system (T3SS), which are
involved in transferring bacterial proteins into eukaryotic host cells
[35,36]. Ligand binding by NAIP leads to the recruitment of NLRC4,
resulting in the activation of NLRC4 and co-assembly, initiating
inﬂammasome formation [37]. Despite containing an LRR, there is
no evidence that NLRC4 acts as the PRR, and while NAIPs act as
PRRs, they do not appear to initiate inﬂammasome assembly in the
absence of NLRC4.
The NAIP:NLRC4 inﬂammasomes are best characterized in mice.
There are seven NAIP proteins in mice; murine NAIP1 and NAIP2
recognize needle proteins of T3SS [36] and the T3SS inner rod pro-
tein PrgJ, respectively, while NAIP5 and NAIP6 bind to bacterial
ﬂagellin [37,38]. Structural studies have given key insights into the
assembly of the NAIP2:NLRC4 and NAIP5:NLRC4 inﬂammasomes
[8,9,39–41] (Fig. 2). The cryo-electron microscopy (cryo-EM) struc-naling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
ture of the protein complex comprising PrgJ, NAIP2 and full-length
mNLRC4 revealed double-layer wheel-like structures comprised of
10, 11, and 12 subunits per layer, while the complex of PrgJ, NAIP2,
and the truncated mNLRC4CARD formed only single-layer struc-
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Fig. 2. Model of NAIP/NLRC4 inﬂammasome assembly. (A) NLRC4 is maintained in an auto-inhibited (non-signaling) state. NAIP5 binds ﬂagellin and undergoes conformational
changes that allow subsequent recruitment and activation of NLRC4. Formation of the inﬂammasome becomes self-propagating, with active NLRC4 molecules recruiting
additional NLRC4 protomers to the assembly. All structures are shown in cartoon and surface representations. (B) A model of the NAIP:NLRC4 inﬂammasome ﬁt to a cryo-EM
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tolume (Electron Microscopy Data Bank [EMDB] ID: 7055). The NLRC4 card domain
he  recruitment of procaspase-1. The inactive NAIP model is based on the structure 
odels without the N-terminal CARD (PDB ID: 6B5B) [40].
ures, indicating that the second layer of the full-length mNLRC4 is
omprised of NLRC4 CARDs [8]. The interactions between the NAIP
nd NLRC4 monomers in the wheel-like assembly are mediated by
oth the NOD and the LRR domain, which form inner and outer
ings, respectively. Oligomerization of the NAIP:NLRC4 assembly
s mediated by complementary charged surfaces, between a posi-
ively charged patch on the NOD of one monomer and a negatively
harged patch on the NOD of an adjacent monomer, and similar
nteractions between the LRRs of adjacent monomers [8]. The orien-
ation of the LRR domain of NLRC4 within the oligomeric assembly
iffers from that of the inactive monomer observed in the crystal
tructure of mNLRC4CARD, with the LRR shifted away from the
OD [8,9]. Notably, each PrgJ:NAIP2:mNLRC4 assembly contains a
ingle NAIP2 molecule, suggesting assembly formation is initiated
y a single PRR [8]. NAIP5:full-length NLRC4 complexes reveal sim-
lar wheel- or disk-like assemblies to those of PrgJ:NAIP2:mNLRC4,
ith 11–12 monomers and rotation of the LRR domains away from
he NOD of NLRC4, compared to the mNLRC4CARD monomer [39].
AIP:NLRC4 oligomerization is unidirectional, with NAIPs having a
ingle charged surface complementary to that of NLRC4. Therefore,
t seems unlikely that NAIP:NLRC4 assemblies would form a closed
ing structure in vivo [9].
The NAIP:NLRC4 studies discussed above applied symmetry that
ssumed the NAIP and NLRC4 protomers to be identical; therefore,
hey failed to reveal the structure of the NAIP or its bound lig-
nd. The cryo-EM structure of NAIP5 in complex with NLRC4 andPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
acterial ﬂagellin, generated without symmetry averaging, instead
evealed an open wheel-like structure [40]. This open structure is
onsistent with the conclusion that NAIPs can only recruit NLRC4
hrough a single donor surface, and that the donor surface of NLRC4thought to cluster in the middle of the wheel-like structure, forming a platform for
ctive NLRC4 (PDB (Protein Data Bank) ID: 4KXF) [34] and activated NAIP and NLRC4
is complementary only to the acceptor surface of adjacent NLCR4
molecules, and not NAIP5. Structural features lost due to the aver-
aging of NAIP and NLRC4 are visible in this structure, for example
an ∼80 amino-acid insertion in the LRR domain and three addi-
tional helices within the NOD of NAIP5 (two of which replace a
phosphorylation site in NLRC4 reported to be crucial for inﬂam-
masome assembly) [42]. In addition to symmetry averaging, the
open and closed structures of NAIP5 and NAIP2 complexes, respec-
tively, could also be protein-speciﬁc, due to the different ligand
(NAIP2: PrgJ; NAIP5: ﬂagellin), molar ratios, or the constructs used
(GST-fused NAIP2; FLAG-fused NAIP5). Irrespective, all structures
support an analogous mechanism of assembly [8,9,40].
In an alternative approach, Yang et al. [41] used NLRC4 with
mutations in the acceptor interface to capture a NAIP5:NLRC4 het-
erodimer in complex with a ﬂagellin derivative, and determined
its structure by cryo-EM. Both the Tenthorey et al. [40] and Yang
et al. [41] structures agree on the structural basis of ﬂagellin sens-
ing, revealing that NAIP5 recognizes several surfaces on the PAMP,
presumably to make pathogen evasion through mutations more
difﬁcult. Both structures also show the location of the N-terminal
BIR domains of NAIP5, with BIR1 playing an important role in the
recognition of the PAMP.
Based on these structural studies, it is apprent that NAIP2 and
NAIP5 undergo conformational changes upon binding of PrgJ and
ﬂagellin, respectively, which is proposed to displace the LRR:NOD
interaction of an auto-inhibited NLRC4, recruiting NLRC4 to thenaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
assembly and inducing similar conformational changes into an
active conformation, allowing NLRC4 to recruit and activate addi-
tional NLRC4 molecules [8,9,39]. The assembly of the NAIP:NLRC4
wheel-like structures positions the N-terminal CARDs into close
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Fig. 3. Death-fold helical assemblies in inﬂammasome signaling. (A) Left, ASC PYDs form a helical ﬁlament (PDB ID 3J63) displaying a three-stranded right-handed geometry,
with  intrastrand interactions mediated by the type I interface, and interstrand interactions mediated by type II and III interfaces. The three strands are colored red, yellow,
and  blue. Right, a schematic diagram of the ASC PYD helical ﬁlament, showing the assembly interfaces. Each PYD is shown as a hexagon; each strand is colored as in the
diagram on the left. (B) Left, procaspase-1 CARDs form a helical assembly (PDB ID 5FNA). The procaspase-1 CARD is reported to be a single-stranded left-handed helix;
however, it displays three-stranded helical geometry similar to that of the ASC PYD ﬁlament when viewed with intrastrand interactions mediated by the type I interface and
i e colo
h ; eac
s ly inte
a
p
b
f
c
m
t
r
t
a
s
i
p
1
t
f
h
h
a
a
n
h
d
A
r
(
t
b
f
I
o
(nterstrand interactions mediated by type II and III interfaces. The three strands ar
elical  ﬁlament, showing the assembly interfaces. Each CARD is shown as a hexagon
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roximity within the centre of the structures. The NLRC4 CARD has
een shown to form helical ﬁlaments in vitro, which can induce the
ormation of procaspase-1 CARD ﬁlaments [9]. This suggests that
lustering of the NLRC4 CARDs within the centre of the oligomer
ay  form a short helical ﬁlament, which protrudes from above
he core of the wheel-like structures, acting as a template for the
ecruitment of ASC or procaspase-1 via homotypic CARD interac-
ions [9,39]. Such nucleated cooperative assembly mechanisms are
 recurring theme among innate immune pathways and demon-
trate how SCAF allows a single PAMP molecule, such as PrgJ, to
nitiate inﬂammasome assembly and recruit multiple effector cas-
ases.
.1.3. Nucleation of ASC PYD ﬁlaments by PYD-containing PRRs
The adaptor protein ASC can be recruited through either its N-
erminal PYD or C-terminal CARD, acting as a bridging molecule to
acilitate recruitment of downstream procaspases. Cryo-EM studies
ave revealed that ASC PYD forms a triple-stranded right-handed
elical ﬁlament, displaying three-fold symmetry along the helical
xis (Figs. 3 and 4). The ﬁlament exhibits three interfaces (type I, II,
nd III) comprised of six surrounding protein surfaces, which are
ow recognized as common interfaces among death-fold domain
elical assemblies [10,11,13,16,43–45]. The type I interaction pre-
ominantly mediates the interactions formed between adjacent
SC PYD monomers within a single helical strand, in particular
esidues of helices 1 and 4 (type Ia interface) and 2 and 3
type Ib interface). Interstrand interactions are mediated by the
ype II and III interfaces. The type II interface involves interactions
etween the loops connecting helices 4 and 5 (type IIa inter-Please cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
ace), and 5 and 6 of the adjacent ASC PYD (type IIb). The type
II interface is mediated by interactions between the 2-3  loop of
ne ASC PYD (type IIIa) and the 1-2 loop of the other subunit
type IIIb) [10].red green, cyan, and magenta. Right, a schematic diagram of the caspase-1 CARD
h strand is colored as in the diagram on the left. (C) DALI pair-wise structure-based
rfaces for the procaspase-1 CARD and ASC PYD are marked by colored circles above
Electrostatic interactions appear vital in all three interfaces;
however, they are particularly prominent in the type I interface,
with mutations within this interface abolishing ﬁlament formation.
Similarly, mutations in the type III interface also abolish ﬁlament
formation, whereas mutations in the type II interface can reduce but
not abolish oligomerization [10]. AIM2 and NLRP3 activation can
initiate ASC PYD ﬁlaments in vivo [46]. Once initiated by the PRR,
ASC forms ﬁlaments comprised of a PYD helical core. The ASC CARDs
are predicted to cluster along the side of the ASC PYD ﬁlament to
allow the recruitment of procaspase-1 [10].
1.1.4. Nucleation of procaspase-1 CARD ﬁlaments
ASC CARDs have been shown to nucleate polymerization of
procaspase-1, which contains an N-terminal CARD and a C-terminal
catalytic domain. Clustering of ASC CARDs is expected to nucleate
procaspase-1 CARD ﬁlaments in vivo and induce proximity-based
proteolytic autoactivation of procaspase-1 to caspase-1. Cleaved
caspase-1 sheds from the CARD ﬁlament, forming active caspase-
1 dimers, which can then process the pro-inﬂammatory cytokines
pro-IL-1 and pro-IL-18, which initiate inﬂammation, and gasder-
min  D, which induces pyroptosis [32,47,48].
The procaspase-1 CARD ﬁlament forms a left-handed one-
stranded helical assembly, consisting of approximately four
subunits per turn, and displays similar type I-III interfaces to those
observed in other helical assemblies by death-fold domains [13].
Unlike the ASC PYD ﬁlament, the type III interface mediates the
intrastrand interactions between the procaspase-1 CARD subunits
in the helical strand, while the type I and II interfaces mediate
interstrand interactions. However, the procaspase-1 CARD ﬁlamentnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
also displays a right handed, 3-stranded helical geometry similar
to the ASC PYD ﬁlament, if the intrastrand interactions are traced
through the type I interface (Fig. 3). Like the ASC PYD ﬁlament, the
type I interface of the procaspase-1 CARD ﬁlament contains exten-
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Fig. 4. ASC CARD helical assembly and its regulation by molecular mimics. (A) ASC CARDs are proposed to provide a template for the recruitment of caspase-1 CARDs, which
form  an open-ended helical ﬁlament that results in caspase-1 activation. (B) The COP INCA inhibits caspase-1 activation by capping the CARD ﬁlament, preventing further
elongation of the CARD ﬁlament and therefore preventing proximity-based auto-activation of the caspase domain. Elongation of the CARD ﬁlament is prevented due to
defective type Ib and IIb interfaces. A similar inhibitory mechanism has been reported for the caspase-8 inhibitor MC159. (C) The COP ICEBERG modulates caspase-1 activity;
however, it is also capable of co-polymerizing with procaspase-1 CARD. It is proposed that co-polymerization of ICEBERG and procaspase-1 CARD modulates proximity based
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auto-activation of the caspase domain by reducing the local concentration of proca
eported for the caspase-8 modulator cFLIP.
ive electrostatic interactions [10,13]. Charge-reversal mutations
n the type I interface abolish procaspase-1 CARD ﬁlament forma-
ion, highlighting the importance of electrostatic interactions at the
ype I interface in helical innate immunity signaling assemblies. An
nalogous mutation within the type II interface also prevents nucle-
tion of the procaspase-1 CARD ﬁlament, whereas charge-reversal
utations in the type III interface do not abrogate ﬁlament forma-
ion, suggesting electrostatic interactions in the type III interface
ontribute little to ﬁlament formation [13].
Similar to the recruitment of procaspase-1 via ASC CARDs, ASC
tself can be recruited by PRRs via homotypic CARD interactions.
SC ﬁlaments form following activation of the NAIP:NLRC4 inﬂam-
asome [49], and ASC CARDs have been demonstrated to form
laments both in vitro and in vivo upon overexpression [28,29,49].
lustering of CARDs in the NAIP:NLRC4 inﬂammasome may  recruit
SC molecules via CARD interactions, inducing the ASC PYDs to
luster and nucleate PYD:DED assemblies.
.1.5. Nucleation of procaspase-8 DED ﬁlaments by ASC PYD
AIM2 and NLRP3 activation has been shown to recruit and acti-
ate procaspase-8 via ASC, to induce apoptotic cell death [24,25]. In
ddition, ASC PYD ﬁlaments have been demonstrated to nucleate
rocaspase-8 DED ﬁlaments both in vitro and in vivo. Combined,
hese data suggest that AIM2 and NLRP3 inﬂammasomes can act
s an alternative platform to the canonical death-inducing signal-
ng complex (DISC) for procaspase-8 recruitment and activation
24,25,50].
Procaspase-8 consists of two N-terminal tandem DEDs (tDED)
nd a C-terminal catalytic domain. The procaspase-8 tDEDs form
riple-stranded right-handed ﬁlaments similar to that of the ASC
YD ﬁlament, with similar type I-III interfaces [43]. In contrast to
SC and CARD ﬁlamentous assemblies, which feature only homo-
eric interactions, the tandem nature of the procaspase-8 tDEDsPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
esults in a combination of homomeric and heteromeric interac-
ions within the ﬁlament.
Like the ASC PYD ﬁlament, the type I interface of the tDED ﬁl-
ment forms the intrastrand interactions. Within each tDED, the-1 and consequent caspase-1 activation. A similar inhibitory mechanism has been
type Ib surface of the ﬁrst DED (DED1) interacts with the type Ia
surface of the second DED (DED2). Conversely, intrastrand inter-
actions between the tDEDs are mediated by the type Ib surface of
DED2 from one tDED and the type Ia surface of DED1 from the
neighbouring tDED. The type II and III interfaces mediate inter-
strand interactions, and appear to be homomeric or heteromeric,
depending on the location of the interface. Type II interactions
between the strands of the triple-strand ﬁlament are homomeric
- DED1 (type IIb):DED1 (type IIa) and DED2 (type IIb):DED2
(type IIa), whereas the type III interactions are heteromeric -
DED1 (type IIIb):DED2 (type IIIa) and DED2 (type IIIb):DED1 (type
IIIa). By contrast, the type II interactions between adjacent triple
strands are heteromeric - DED1 (type IIb):DED2 (type IIa) and
DED2 (type IIb):DED1 (type IIa), and the type III interactions are
homomeric - DED1 (type IIIb):DED1 (type IIIa) and DED2 (type
IIIb):DED2 (type IIIa) [43]. Unlike the highly electrostatic nature
of the type I interface observed in PYD and CARD ﬁlaments, the
type I interface of the tDED ﬁlament is predominantly medi-
ated by hydrophobic interactions, whereas the type II and III
interactions are predominantly hydrophilic and feature comple-
mentary electrostatic interactions. Both charge-reversal mutations
in the type II and type III interfaces and mutations of hydropho-
bic residues in the type I interface impair tDED ﬁlament formation
[10,13,43].
The mechanism by which ASC induces polymerization of
procaspase-8 tDED ﬁlaments is unknown. However, gold labelling
of ASC PYD and procaspase-8 DED indicates that the ASC PYDs
are only located at a single end of the procaspase-8 DED ﬁlament
[24]. This suggests that the ASC PYD ﬁlament acts as a template for
the recruitment of procaspase-8, which then assembles along the
same helical trajectory as that of the ASC PYD, forming a contin-
uous ﬁlament. Mutations in the ASC PYD that diminish ASC PYD
and procaspase-8 interactions are mapped to residues in the type Inaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
and III interfaces of the ASC PYD ﬁlament. Mutations in the type Ia,
type Ib, and type IIIb surfaces have all been shown to disrupt ASC
PYD self-association, as well as the ASC PYD:procaspase-8 interac-
tions [24], further suggesting a cooperative assembly mechanism
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here the ASC PYD ﬁlament acts as a template for the formation of
rocaspase-8 assemblies.
The structures of inﬂammasome helical signaling assemblies
ave been reported as varying helical arrangements, with the
rocaspase-1 CARD ﬁlaments forming left-handed single-stranded
elical assemblies similar to those of RIG-I:MAVS and the myd-
osome assemblies (see Section 1.2 and 1.3), and ASC and
rocaspase-8 ﬁlaments forming right-handed triple-stranded heli-
al assemblies [10,24,43]. However, procaspase-1 CARD, ASC PYD,
rocaspase-8 tDED and RIG-I:MAVS ﬁlaments all display a similar
ight-handed triple-stranded helical geometry when intrastrand
nteractions are traced through the type I interface. Furthermore,
he signaling mechanisms are conceptually the same and conform
o SCAF.
.2. RIG-I:MAVS signalosome assembly
Notable PRRs in the RLR family are RIG-I and MDA5. They rec-
gnize cytosolic viral RNA and drive the production of type-1
nterferons (IFNs) and other pro-inﬂammatory cytokines [51,52].
IG-I and MDA5 share a common domain architecture, comprised
f an N-terminal region consisting of tandem CARDs, a central
ExD/H box RNA helicase domain, and a C-terminal domain (CTD)
ontaining a repressor domain (RD) at its C-terminus. In unin-
ected cells, RIG-I and MDA5 signaling is suppressed by constitutive
hosphorylation of their CARDs and sequestering of the tandem
ARDs by the helicase domain. Binding of dsRNA triggers con-
ormational changes, followed by the binding of ATP and ATP
ydrolysis within the helicase domain, and ﬁnally release of the
ARDs, which can then be dephosphorylated by PP1 (protein phos-
hatase 1) isoforms PP1 and PP1 [22,53]. Once activated, the
ExD/H box RNA helicase domain and the CTD form ring-like struc-
ures around dsRNA that expose the tandem N-terminal CARDs,
llowing interaction with the N-terminal CARD of the adaptor
rotein MAVS (mitochondrial anti-viral signaling), which recruits
RAFs (tumor necrosis factor receptor-associated factors) 2, 5,
nd 6 to activate type-1 IFNs [45,53–57]. The RLR family mem-
er LGP2 (laboratory of genetics and physiology-2) contains the
NA helicase domain and CTD, yet lacks the tandem N-terminal
ARDs found in RIG-I and MDA5, which facilitate downstream
ignaling. The role of LGP2 in innate immune signaling is not
learly established; however, current evidence suggests that LGP2
cts as a positive regulator of MDA5-mediated antiviral signaling
58].
The crystal structure of the RIG-I tandem CARDs [57] and the
ryo-EM structure of a ﬁlament of MAVS CARDs [45] reveal left-
anded single-stranded helical structures (Fig. 5). Unlike MAVS
ARD ﬁlaments, the RIG-I tandem CARD assembly is limited to
hat of a tetramer of tandem CARDs; a helical rise half the thick-
ess of the ﬁlament and the tandem nature of the RIG-I CARDs
terically prevents the incorporation of further subunits, result-
ng in a structure resembling a lock-washer. While the structure
f MDA5 tandem CARDs is unknown, they are presumed to form
imilar assemblies [45,57]. Clustering of MDA5 or RIG-I tandem
ARDs, following the formation of MDA5 or RIG-I ﬁlaments bound
o dsRNA, acts as a scaffold for binding of the MAVS CARDs, result-
ng in MAVS CARD ﬁlament formation. The crystal structure of a
etramer of RIG-I tandem CARDs in complex with four MAVS CARDs
aught in the act of starting a MAVS CARD ﬁlament [45] reveals that
he helical assembly of RIG-I tandem CARDs acts as a template for
he formation of MAVS CARD ﬁlaments, by recruiting MAVS CARDsPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
long the same helical trajectory as the RIG-I tandem CARD assem-
ly. Following nucleation of MAVS CARD ﬁlaments by RIG-I, MAVS
RAF-binding sites cluster to recruit TRAF and activate downstream
ignaling [45]. PRESS
pmental Biology xxx (2018) xxx–xxx 7
1.3. TLR signalosome assembly
TLR signal transduction is triggered by binding of a PAMP or
DAMP by a TLR, with subsequent dimerization of the receptor [59].
TLRs then recruit a single, or speciﬁc combination of cytosolic TIR
domain-containing adaptor proteins via TIR:TIR interactions [60],
leading to downstream activation of the transcription factors NF-
B (nuclear factor kappa-light-chain-enhancer of activated B cells),
AP-1 (activator protein 1) and IRFs (interferon regulatory factors),
to drive immune responses and inﬂammation [61].
The adaptors involved in TLR signaling are MyD88 (myeloid dif-
ferentiation primary response gene 88), MAL  (MyD88 adaptor-like
protein), TRIF (TIR domain-containing adaptor protein inducing
IFN), and TRAM (TRIF-related adaptor molecule) [60]. MyD88 is
required for signaling by all TLRs except for TLR3, which uses TRIF
alone. MAL  and TRAM are membrane-associated adaptors bridg-
ing TLRs and MyD88, and TLRs and TRIF, respectively. The ﬁfth
adaptor, SARM (sterile- and TIR motif containing protein), can act
as a speciﬁc inhibitor of TRIF-mediated TLR3 and TLR4 signaling,
but also functions in neuronal axon degeneration [62,63] and cell-
death pathways (reviewed by [64]). The sixth adaptor, BCAP (B cell
adaptor for PI3K), links phosphoinositide metabolism with negative
regulation of TLR pathways [65,66].
Structures of both receptor and adaptor TIR domains are avail-
able [67]. The highly-conserved BB-loop of the TIR domain, which
links the B-strand to the B-helix, has long been known to
play a role in TLR signaling, but how this is accomplished at the
molecular level has remained controversial [68–77]. Our studies
using in vitro reconstitution, polymerization assays and electron
microscopy revealed that the TIR domain of MAL  can either self-
assemble or assemble with the TLR4 TIR domain into ﬁlaments,
and that MAL  can induce formation of large MyD88 TIR-domain
assemblies [15]. As part of this study, a cryo-EM structure of
the MAL  ﬁlament revealed proto-ﬁlaments that consist of two
parallel strands of TIR-domain subunits in a BB-loop-mediated
head-to-tail arrangement (Fig. 6A). Furthermore, a projection map
of the MAL-induced MyD88 TIR domain assemblies suggests that
they are also constructed from similar two-stranded head-to-tail
arrays. Two types of asymmetric TIR:TIR interfaces were identi-
ﬁed in the proto-ﬁlament: one within each of the two strands
and one between the two  strands (Fig. 6B). Structure-based muta-
genesis conﬁrms the importance of these TIR-domain interfacial
residues in both MAL  and MyD88 assembly formation, and exten-
sive published MAL  and MyD88 mutagenesis data also conﬁrm the
importance of both interfaces for the activation of the transcrip-
tion factor NF-B downstream in the signaling pathway. Although
it is unlikely that similar-scale TIR-domain assemblies are formed
during normal TLR signaling in the cell [78], the MAL  TIR-domain
proto-ﬁlament structure reﬂects the molecular mechanisms of
TIR:TIR interactions during this process, which are used to assemble
open-ended TLR4:MAL:MyD88 complexes. Several of the residues
in the interfaces of the MAL  proto-ﬁlament are highly conserved
in mammalian TIR domains, suggesting that this may be a gen-
eral mechanism of TIR-domain assembly formation in TLR and IL-1
receptor signaling [15].
MyD88 also possesses an N-terminal DD, which forms an
oligomeric assembly with IRAKs (interleukin-1 receptor-associated
kinases) through DD interactions. This complex, called the myd-
dosome, brings the kinase domains of IRAKs into proximity for
auto- and cross-phosphorylation and activation [79]. The crystal
structure of the complex of MyD88, IRAK4, and IRAK2 DDs reveals
that the myddosome forms a left-handed one-start helical assem-naling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
bly, consisting of six MyD88, four IRAK4, and four IRAK2 DDs  [11].
Three types of interfaces (types I-III) are observed in the quaternary
structure, with each molecule interacting with up to six adjacent
molecules. Although the stoichiometry of MyD88:IRAK4 in solu-
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Fig. 5. Death-fold helical assemblies in RLR signaling. (A) The RIG-I tandem CARD forms a helical template for MAVS polymerization. MAVS CARDs are recruited to the RIG-I
tandem CARD and form a ﬁlament, which extends along the helical trajectory deﬁned by RIG-I. The RIG-I tandem CARD and the MAVS CARD from the RIG-I CARD:MAVS CARD
crystal structure (PDB ID: 4P4H) are colored green and blue, respectively; the MAVS CARD ﬁlament is displayed purple. (B) The RIG-I:MAVS CARD helical assembly is reported
to  be a single stranded helix; however, it displays a three-stranded left-handed geometry, when viewed with intrastrand interactions mediated by the type I interface. The
t  in dar
h n; ea
t
t
d
[
d
s
[
i
i
1
n
a
i
(
a
n
b
(
t
T
i
w
n
U
R
ﬁ
phree  strands are colored yellow, magenta, and cyan; RIG-I subunits are displayed
elical  assembly, showing the assembly interfaces. Each CARD is shown as a hexago
ion appears to vary between 6–8 MyD88 and 3-4 IRAK4 molecules,
he interactions and assembly of the myddosome are maintained
espite the variable stoichiometry [61,80].
Although less is known about TRIF-dependent TLR signaling
81], cellular localization studies have shown that TRIF alters its
istribution proﬁle from a diffuse cytoplasmic distribution to a
peckle-like structure in response to TLR3 interaction with dsRNA
82,83]. Both the TIR domain and the C-terminal RHIM (receptor
nteracting protein [RIP] homotypic interaction motif) domain are
nvolved in TRIF oligomerization [83,84].
.4. Necrosome assembly
Necroptosis, or programmed necrosis, is a regulated form of
ecrosis and an alternative mode of cell death when caspase
ctivity is inhibited in cells expressing the protein RIP3 (receptor-
nteracting protein kinase 3). Stimulated by members of the TNF
tumor necrosis factor) and TLR superfamilies, necroptosis is initi-
ted by the formation of multimeric signaling complexes termed
ecrosomes. The core components of the necrosome appear to
e RIP1 and RIP3 (sometimes called RIPK1/3), as well as MLKL
mixed lineage kinase domain-like protein). RIP1 plays a role in
he activation of caspase-8, upon recruitment by either activated
NF receptor 1 or TRIF through activated TLR3 or TLR4. RIP1, act-
ng as an adaptor protein, recruits FADD (Fas-associated protein
ith death domain) through its C-terminal DD, which in turn
ucleates caspase-8 oligomerization and auto-processing [85–87].Please cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
pon inhibition of caspase-8 in RIP3-expressing cells, RIP1 and
IP3 interact via their RHIM domains, forming an amyloid-like
bril [88]. Phosphorylation of RIP1 and RIP3, either by cross-
hosphorylation or auto-phosphorylation, leads to the recruitmentker shades of the strand colors. (C) A schematic diagram of the RIG-I:MAVS CARD
ch strand is colored as in B.
and phosphorylation of the executioner molecule MLKL, triggering
its oligomerization and cell membrane permeabilization [89,90].
The RIP1:RIP3 amyloid ﬁbril that forms the basis of the necro-
some is mediated by 16 residues of the RIP1 RHIM domain
(T532–Y544 and Y546–E548) and six consecutive residues of
the RIP3 RHIM domain (G457–D462). Mutations in these regions
results in either partial or complete dissociation of RIP1:RIP3 com-
plexes, and in at least some cases (G457D, V458P, and V460P
mutations in RIP3) prevents cell death from TNF-induced necro-
sis, highlighting the requirement of RIP1:RIP3 oligomerization for
the initiation of necroptosis [88].
RIP3-mediated phosphorylation of Thr357 and Ser358 in the C-
terminal kinase-like domain of MLKL has been shown to induce
MLKL oligomerization, leading to necroptosis [91]. Despite the
essential role of the necrosome in necroptosis, there is no high-
resolution model of the RIP1:RIP3 amyloid ﬁbril, and the MLKL
residues phosphorylated by RIP3 (Thr357 and Ser358) are dis-
ordered in the crystal structure of the RIP3 kinase domain in
complex with the mouse MLKL kinase-like domain [92]. Constructs
containing only the kinase-like domain do not form oligomers, sug-
gesting that phosphorylation activates the N-terminal four-helix
bundle (4HB) domain of MLKL, which carries out the execu-
tioner function of MLKL. Davies et al. [90] suggest that in its
inactive state, the kinase-like domain of MLKL serves an auto-
inhibitory function, inhibiting the executioner activity of the 4HB
domain. Once phosphorylated, the central brace helices con-
necting the N-terminal 4HB domain and C-terminal kinase-likenaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
domain mediate oligomerization and activation of MLKL. Fol-
lowing activation, MLKL is thought to translocate to the plasma
membrane, and permeablize the membrane, leading to membrane
rupture and cell death. In this context, necroptosis not only serves
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Fig. 6. TIR-domain helical assemblies in TLR signaling and their regulation by molecular mimics. (A) MAL  TIR domain proto-ﬁlament shown in cartoon representation (PDB ID
5UZB).  The proto-ﬁlament consists of two parallel strands of TIR-domain subunits in a BB-loop-mediated head-to-tail arrangement. (B) A schematic diagram of the MAL  TIR
domain  ﬁlament, showing the assembly interfaces. BB surface: BB loop; EE surface: D, E strands and E helix; BC surface: B and C helices; CD surface: D helix and CD
loop.  (C) Negative regulation of the TLR4 signalosome by pathogen proteins. TcpC from uropathogenic E. coli targets TLR4 and MyD88 TIR domains by an undeﬁned mechanism.
Vaccinia  virus A46 and Brucella TcpB target the receptor-adaptor interactions (either TLR4 or MAL  TIR domains). A46 also targets the MyD88 TIR domain. Modulations by
pathogen proteins (represented by T-shaped red lines) may  lead to the disruption of TLR4-mediated SCAF (lower panel) and the inhibition of mammalian protective immune
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s an alternative cell-death pathway in response to pathogens
ttempting to subvert other immune responses, but also as a
echanism to release PAMPs and DAMPs to heighten immune
esponses.
.5. Advantages of SCAF compared to classical signaling
echanisms
The advantages of SCAF as a signaling mechanism are likely
ultifaceted, as cooperative assembly formation can provide a
echanism for taking advantage of weak interactions between
inding partners and allow the formation of self-perpetuating
ystems after initial nucleation. The oligomerization or cluster-
ng of assembly components observed in SCAF would greatly
ncrease the local concentration of effector enzymes, facilitating
roximity-based autoactivation as observed for procaspases andPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
RAKs, following the formation of inﬂammasomes and myddo-
omes, respectively [4,11,13,93]. Spatial conﬁnement within the
ell resulting from signalosome assembly would also increase
he probability of binding events between interacting partnersaces. In the inset, different color-codes represent the components and inhibitors of
nly).
[93]. This combination of cooperativity and higher-order assem-
blies observed in SCAF would also allow low-levels of activated
PRRs to yield a strongly ampliﬁed activation of downstream effec-
tor enzymes, providing high sensitivity to a minute amount of
PAMPs or DAMPs. As such, SCAF as a signaling mechanism is
particularly suited to the needs of the innate immune system
[1,4,6].
2. Negative regulation of SCAF in innate immunity
pathways by molecular mimics
The use of repeating subunits and conserved interfaces within
signalosomes allows for negative regulation of innate immune
signaling pathways through the disruption of the assembly
by molecular mimics of assembly components. Such molecules
include a range of virulence factors identiﬁed in bacterial and viralnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
pathogens used to evade or prevent immune system responses, as
well as host decoy proteins presumed to play a role in the regula-
tion of innate immune signaling by preventing unwarranted signal
transduction.
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.1. Inhibition of inﬂammasome signaling
.1.1. CARD and PYD-only proteins
Considering the essential role of CARDs and PYDs in ﬁlamen-
ous signaling assemblies of the inﬂammasome, it is not surprising
hat a number of CARD-only proteins (COPs) and PYD-only pro-
eins (POPs) have been shown to modulate inﬂammasome signaling
Table 1). COPs and POPs are predominantly found in higher pri-
ates, and thus likely serve regulatory roles in inﬂammasome
ignaling. Some viral COPs and POPs, on the other hand, are linked to
he disruption of inﬂammasome signaling, presumably as a means
f evading host defenses.
.1.1.1. Human COPs. Three COPs have been identiﬁed in humans
ased on high sequence similarity to procaspase-1 CARD. CARD-
nly protein 1 (COP1), inhibitor of CARD (INCA), and ICEBERG
interleukin-1 converting enzyme [ICE]/caspase-1–BERG) all con-
ain a CARD motif, yet lack the caspase domain required for
ctivation of pro-IL-1, pro-IL18 and gasdermin D [13,94–97].
INCA has been shown to inhibit procaspase-1 recruitment and
ctivation with nanomolar potency, by binding the procaspase-1
ARD ﬁlament and preventing ﬁlament elongation. INCA directly
inds procaspase-1 through type Ia, IIa, IIIa, and IIIb interfaces
ommon among the death-fold helical assemblies; however, INCA
isplays defective type Ib and IIb interfaces, preventing procaspase-
 polymerization, and caspase-1 dependent IL-1 secretion [13]
Fig. 4). Expression of INCA is upregulated by IFN- and INCA has
een shown to physically interact with procaspase-1 ﬁlaments and
revent ﬁlament elongation [97].
Human COP1 and ICEBERG directly interact with procaspase-1
ARD, and have been reported to inhibit caspase-1 induced IL-1
aturation [94–96]. ICEBERG can nucleate and co-polymerize with
rocaspase-1 CARD ﬁlaments (Fig. 4C), thus any inhibitory effect
n caspase-1 induced activation of IL-1 occurs via a mechanism
ifferent to INCA, and not as a result of disruption of ﬁlament for-
ation [13]. COP1 is also thought to polymerize together with
aspase-1 in a manner similar to ICEBERG. The COP1 CARD dif-
ers from the caspase-1 CARD by only three residues, and as two
f these residues reside in the predicted ﬁlament interfaces, and
re conserved in ICEBERG, COP1 is unlikely to prevent CARD ﬁl-
ment formation [13,96]. Likewise, COP1 has also been shown to
elf-oligomerize in immunoprecipitation experiments [96].
The inhibition of caspase-1 dependent IL-1 secretion by COP1
nd ICEBERG is linked to inhibition of RIP2-based activation of
aspase-1, by blocking procaspase-1 CARD:RIP2 CARD interactions
nd preventing activation of caspase-1 [94–96]. Similarly, COP1 and
CEBERG may  also be able to reduce procaspase-1 proximity-based
utoactivation by reducing the local concentration of caspase-
 present in ﬁlamentous signaling assemblies (Fig. 4). However,
he roles of COP1 and ICEBERG as negative regulators of the
nﬂammasome are contentious, with conﬂicting reports of COP1
verexpression increasing and decreasing IL-1 secretion, and
CEBERG similarly inhibiting IL-1 secretion in some cases and
howing negligible inhibition in other studies [13,98].
.1.1.2. CARD-containing protein 8 (CARD8). CARD8, also referred
o as TUCAN (tumor-up-regulated CARD-containing antagonist of
aspase nine) or Cardinal (CARD inhibitor of NF-B-activating
igands), contains a C-terminal CARD and an N-terminal FIIND
function to ﬁnd) domain, and thus is not strictly considered a
OP. Notably, CARD8 has been demonstrated to bind procaspase-
 in a competitive manner with regards to COP1 and ICEBERG, asPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
ell as inhibit the activation of caspase-1 and subsequent secre-
ion of IL-1. Co-transfection of human embryonic kidney (HEK)
93T cells with CARD8 and RIP2 also demonstrated diminished
IP2-induced activation of caspase-1, which further suggests that PRESS
pmental Biology xxx (2018) xxx–xxx
COP1 and ICEBERG also inhibit activation of caspase-1 by block-
ing caspase-1:RIP2 binding [99]. The observation that CARD8 CARD
binds the procaspase-1 CARD and inhibits caspase-mediated IL-1
secretion suggests that CARD8 also prevents procaspase-1 CARD
oligomerization or co-localizes with procaspase-1 CARD in ﬁla-
mentous signaling assemblies. CARD8 also serves as a regulator of
the NLRP3 and NOD2 (nucleotide-binding oligomerization domain-
containing protein 2, also called NLRC2) assemblies, through
binding to their nucleotide-binding domains. CARD8 has previously
been suggested to induce caspase-1 activation upon overexpres-
sion, and to act as an adaptor to aid in the recruitment of caspase-1
in NLRP3 inﬂammasomes consisting of NLRP3, ASC, caspase-1, and
CARD8 [100]. However, this is in stark contrast to more recent ﬁnd-
ings that show that CARD8 negatively regulates NLRP3 and NOD2
signaling. The CARD8 FIIND inhibits NOD2 homo-oligomerization
as well as NLRP3-induced oligomerization of ASC, ultimately lead-
ing to decreased activation of caspase-1 and pro-inﬂammatory
cytokines [101].
2.1.1.3. Viral COPs. Viruses have captured and modiﬁed host genes
to encode vCOPs and vPOPs and subvert the host’s innate immu-
nity [102]. The grouper iridovirus (GIV) from the Iridoviridae family
encodes a COP (GIV-CARD) that shows high similarity to the human
COP ICEBERG. GIV-CARD exhibits anti-apoptotic activity [103],
although the mechanism is unknown. Another study identiﬁed a
COP (64R) in frog virus 3 (FV3) as important for viral pathogenesis,
with deletion of 64R triggering more apoptosis in Xenopustadpoles,
compared to the wild-type FV3 [104]. Therefore, vCOPs presumably
interfere with immune signaling in a similar manner to mammalian
COPs, but structural and biochemical studies are needed to decipher
their detailed mechanisms of action.
2.1.1.4. Human POPs. The human genome codes for four POPs
(POP1-4), with POP1-3 demonstrated to disrupt inﬂammasome sig-
naling and to modulate cytokine activation [105–110]. POP1 shares
a high degree of similarity with ASC PYD (64% sequence identity
and an r.m.s.d. of 1.2 Å over 89 residues when the structures are
compared [111]). POP1 co-localizes with ASC in perinuclear specks
(inﬂammasome assemblies) and co-immunoprecipitates with ASC
PYD, conﬁrming that POP1 speciﬁcally binds ASC through PYD:PYD
interactions. POP1 inhibits inﬂammasome formation and signal-
ing in several ways [105,112]. It inhibits NLRP3-induced ASC PYD
polymerization and subsequent caspase-1 activation, and conse-
quently inhibits activation of the pro-inﬂammatory cytokines IL-1
and IL-18 [112]. Presumably, it prevents NLRP3-induced nucleation
of ASC assemblies by binding to ASC PYD and blocking the NLRP3
PYD binding site. Although not clearly established, binding of POP1
to ASC PYD is also likely to prevent ASC PYD self-polymerization.
Incorporation of POP1 into ASC specks renders the signaling assem-
bly inactive, abolishing IL-1 release [112]. Overall, POP binding
would seemingly reduce the local concentration of ASC, and inhibit
the clustering of ASC CARDs required for procaspase-1 recruitment
and subsequent polymerization and processing to caspase-1.
POP2 displays a greater level of similarity with the PYDs of
the receptors NLRP2 and NLRP7 (∼70% and 50% sequence identity,
respectively) than those of ASC or POP1 (40% and 37% sequence
identity, respectively). POP2 has been shown to interact with ASC
PYD and NLRP2 in co-immunoprecipitation and yeast-two-hybrid
assays [113]. Yeast-two-hybrid screens indicate POP2 also inter-
acts with NLRP1, 4, and 12, but not NLRP3, 10, and 11 [113].
Like POP1, POP2 co-localizes with ASC in perinuclear specks, andnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
while it has not been shown to directly interact with NLRP3,
disrupts NLRP1, NLRP2, and NLRP3 nucleation of ASC assem-
blies and inﬂammasome signaling. This leads to decreased release
of TNF- and IL-1, presumably at least in part due to the
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Table  1
Molecular-mimic negative regulators of inﬂammasome signaling.
Protein Organism Structure Mechanism of action References
COP1 Human hCOP Binding to procaspase-1 CARD ﬁlament [96]
INCA  Human hCOP Capping procaspase-1 CARD ﬁlament [13]
ICEBERG Human hCOP Binding to procaspase-1 CARD ﬁlament [13]
CARD8  Human FIIND and CARD Binding to procaspase-1 CARD ﬁlament [99]
GIV-CARD Grouper iridovirus vCOP Inhibition of apoptosis [103]
64R  Frog virus 3 vCOP Inhibition of apoptosis [104]
POP1,  POP2 Human hPOP ASC PYD binding [105,107,112,114]
POP3  Human hPOP AIM2 and IFI16 PYD binding [108]
POP4  Human hPOP Unknown
M013L Rabbit myxoma virus vPOP ASC PYD binding [118]
gp013L Shope ﬁbroma virus vPOP ASC binding [120]
18L  Yaba-like disease virus vPOP Unknown [121]
gp024 Deerpox virus vPOP Unknown [122]
SPV14L Swinepox virus vPOP Unknown [123]
cFLIPS Human tDED (cFLIP) Binding to procaspase-8 ﬁlament [43,125]
cFLIPL Human tDED (cFLIP), inactive
caspase-like domain
Binding to procaspase-8 tDED ﬁlament,
heterodimer with caspase-8 caspase
[115,126]
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mpaired ASC oligomerization-induced recruitment and activation
f procaspase-1 [107,114].
In contrast to POP1 and POP2, POP3 does not directly bind ASC.
nstead, POP3 disrupts inﬂammasome signaling through interac-
ion with the PYD of the PRRs of the PYHIN family, AIM2 and IFI16
108]. AIM2 and IFI16 bind bacterial or viral DNA via their HIN200
omain, and then recruit ASC through homotypic PYD interactions
o initiate caspase-1 activation [27,115–117]. In human primary
acrophages transfected with adenovirus encoding POP3, this
OP has been demonstrated to co-localize with endogenous AIM2
nd IFI16. In THP-1 cells transfected with adenovirus encoding
OP3 and primed with modiﬁed vaccinia virus Ankara (MVA),
OP3 disrupts AIM2:ASC assemblies. Consistent with this, POP3
lso prevents AIM2-induced ASC oligomerization in HEK293 cells
ctopically expressing ASC and AIM2 [108]. Silencing of POP3
xpression in human primary macrophages using small interfer-
ng RNA (siRNA) results in enhanced release of IL-1 and IL-18
n response to the presence of cytosolic dsDNA (poly-dA:dT) or
nfection with MVA, but not in response to the activation of TLR4
y LPS, the NLRP1 inﬂammasome by the lethal toxin of Bacil-
us anthracis or muramyl dipeptide, the NLRP3 inﬂammasome in
esponse to monosodium urate (MSU) crystals or silica, or the
LRC4 inﬂammasome in response to Salmonella Typhimurium
agellin. By contrast, THP-1 cells transfected with adenovirus
ncoding POP3 showed reduced release of IL-1 and IL-18 in
esponse to poly-dA:dT, infection with MVA, and infection with
ouse cytomegalovirus (MCMV), but not MSU  crystals. More-
ver, procaspase-1 activation was impaired in POP3-expressing
one marrow-derived macrophages infected with MVA  or MVCV,
ut not those treated with LPS and ATP, indicating that POP3
peciﬁcally inhibits DNA-induced PYHIN inﬂammasome signaling
108].
.1.1.5. Viral POPs. Rabbit myxoma virus encodes the POP M013L
hat resembles human POP1 and ASC. Ectopically expressed M013L
nhibited caspase-1 activation, dampened IL-1 and IL-18 secre-
ion, and was shown to both co-localize and interact with ASC
YD [118]. M013L is important for pathogenesis, withy deletion
f M013L resulting in attenuated virulence [119]. Genome analyses
f other Poxviridae viruses also identiﬁed vPOPs, including ShopePlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
broma virus gp013L [120], Yaba-like disease virus 18L [121], deer-
ox virus gp024 [122] and swinepox virus SPV14L [123]. Among
hem, Shope ﬁbroma virus gp013L shares 59% sequence identity
ith the myxoma virus M013L, and has been shown to both inter-domain
Capping procaspase-8 tDED ﬁlament [43,128]
act with ASC in vitro and co-localize with ASC in vivo in perinuclear
specks [102,113].
2.1.2. DED inhibitory proteins
In addition to COPs and POPs, the DED-containing caspase-8
(also called FLICE) inhibitory proteins (FLIPs) have been shown
to modulate inﬂammasome signaling. FLIPs can be of cellular
(cFLIP) or viral (vFLIP) origin [124]. cFLIPs exist as three iso-
forms in humans, a long isoform referred to as cFLIPL, and two
short isoforms known as cFLIPR and cFLIPS. While the long form
contains an N-terminal tDED and a C-terminal inactive caspase-
like domain, the two short isoforms contain only the N-terminal
tDED. The tDED of cFLIP forms ﬁlaments in vitro and likely co-
polymerizes with caspase-8 [43]. The short forms of cFLIP have
been shown to inhibit caspase-8 activation [43,125] and modulate
caspase signal transduction in a manner similar to that proposed
for COP1 and ICEBERG; incorporation of cFLIPS into the ﬁlament
may  reduce the local concentration of activated caspase-8, suf-
ﬁciently to inhibit procaspase-8 proximity-based autoactivation.
The inactive caspase-like domain of cFLIPL can form heterodimers
with the caspase domain of caspase-8, forming a caspase-8:cFLIPL
heterodimer with substrate speciﬁcity different to that of caspase-
8 alone [126,127]. Interestingly, high levels of cFLIPL have been
reported to inhibit procaspase-8 activation, whereas low concen-
trations of cFLIPL promote procaspase-8 activation [125]. cFLIPL
may  have a similar role to the short forms of cFLIP, dependent on
its expression level; however, the differing substrate speciﬁcity of
the caspase-8:cFLIPL heterodimer implies that cFLIPL may  also have
roles in non-canonical signaling pathways.
Unlike cFLIPs, the vFLIP MC159 from the Molluscum contagio-
sum virus inhibits caspase-8 activation but does not form ﬁlaments
[43,128]. MC159 has been shown not only to inhibit apoptosis, but
also to inhibit nucleation of the procaspase-8 tDED ﬁlaments and
elongation of preformed ﬁlaments, suggesting that MC159 directly
binds to procaspase-8 and blocks ﬁlament formation in a mecha-
nism similar to the inhibition of procaspase-1 CARD polymerization
by INCA [13].
Comparison of MC159 and procaspase-8 tDED ﬁlament surfaces
revealed that the type IIb and type IIIb surfaces of DED1 and DED2
are preserved and facilitate binding to the type IIIa surface of DED1naling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
and type IIa surface of DED2, respectively. However, the type IIa
and IIIa interfaces are defective, presumably due to a lack of elec-
trostatic complementarity to the procaspase-8 DEDs, preventing
bound MC159 from recruiting additional procaspase-8 or MC159
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olecules, thus capping the ﬁlament and preventing polymeriza-
ion and signaling [43].
.2. Inhibition of RLR signaling
Inhibition of RLR/MAVS-mediated immune responses is com-
on  among many viruses. The inhibition can occur via a wide
ange of mechanisms, which can be broadly categorized as either
etection evasion or signaling inhibition (Table 2).
Viral mechanisms of avoiding detection by the cytoplasmic PRRs
nd preventing downstream RLR:MAVS oligomerization include
equestering the viral genome in intracellular compartments
129,130] and shielding the PAMPs from RLRs through viral or
ost proteins that bind viral dsRNA and prevent interaction with
he PRRs. The virus proteins 35 (VP35) of Ebola and Marburg
iruses bind viral dsRNA and prevent activation of RIG-I and MDA5
131–134]. Similarly, respiratory syncytial virus (RSV) recruits the
ost protein La to sequester viral RNA and prevent RIG-I acti-
ation [135]. Several viruses from the Bunyaviridae, Bornaviridae,
nd Arenaviridae families have also been shown to modify the 5′
riphosphate moiety of the viral RNA, thus inhibiting RIG-I activa-
ion [136–139]. Rather than sequestering viral nucleic acids, the V
roteins of paramyxoviruses sequester PP1 to avoid detection by
DA5. The V proteins of measles and Nipah viruses act as decoy
ubstrates of PP1 and PP1, preventing dephosphorylation of
DA5 CARDs and thus MDA5 activation, allowing evasion from the
nnate immune system [140].
The non-structural proteins NS1 and NS2 from RSV inhibit
LR:MAVS signaling by preventing RIG-I:MAVS interactions
hrough direct binding to either RIG-I or MAVS [141,142]. RSV
S1 has been shown to co-localize with MAVS at the mito-
hondria in human epithelial lung carcinoma A549 cells infected
ith recombinant RSV, or transfected with RSV NS1. Further-
ore, co-immunoprecipitation with MAVS or NS1, followed by
mmunoblotting with anti-RIG-I, anti-MAVS or anti-NS1 anti-
odies, suggests that NS1 directly binds to MAVS and inhibits
IG-I:MAVS binding in a dose-dependent manner [142]. This
nteraction appears speciﬁc for MAVS and not RIG-I, with no inter-
ction between NS1 and full-length RIG-I detected. By contrast,
SV NS2 has been reported to disrupt innate immune system
ntiviral responses by directly binding to the tandem CARD-
ontaining region of RIG-I, preventing downstream recruitment
f MAVS and thus subsequent MAVS oligomerization [141]. Co-
mmunoprecipitation experiments with cytoplasmic extracts from
EK293T cells co-transfected with NS2 and RIG-I (full length, N-
erminal fragments, or C-terminal fragments) revealed that the
-terminal CARD-containing region of RIG-I was required for inter-
ction with NS2, whereas no interaction was detected with the
-terminal fragment of RIG-I [141].
In addition to inhibiting the deposphotylation of MDA5 CARDs,
he V proteins of some paramyxoviruses, including parainﬂuenza 5
nd measles viruses, modulate innate immune signaling and inter-
eron production by binding to MDA5 and disrupting downstream
ignaling [140]. The C-terminal domains of V proteins bind specif-
cally to the helicase domain of MDA5 but not RIG-I, inducing a
onformational change that disrupts the ATPase activity of MDA5
equired to induce oligomerization of MAVS CARDs, ultimately pre-
enting MAVS-dependent anti-viral signaling [143,144].
.3. Inhibition of TLR signaling
Both bacteria and viruses contain proteins that dampen the pro-Please cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
ective inﬂammatory responses by targeting the TLR pathways.
uch bacterial (but not viral) proteins usually contain TIR domains
nd have been called Tcps (TIR domain-containing proteins). Both
acterial and viral proteins inhibit the interactions between recep- PRESS
pmental Biology xxx (2018) xxx–xxx
tors and adaptors, although the mechanisms may  be different
(Table 3, Fig. 6C).
2.3.1. Inhibition of TLR signaling by bacterial Tcps
Bioinformatic analyses have shown that TIR domains are
widespread in bacteria [145,146]. Although the majority of these
Tcps are thought to function as general-purpose protein:protein
interaction domains or metabolic regulatory enzymes [147], a
subset from human pathogens have been shown to suppress TLR-
mediated NF-B activation, suggesting that these Tcps are involved
in virulence and suppression of the host innate immune responses.
Among them, the molecular basis of innate immune suppression
has been studied most for Brucella melitensis TcpB (also called BtpA
or Btp1) [148–152] and the uropathogenic E. coli protein TcpC
[153–155]. The crystal structures of TcpB [148–150] and Para-
coccus denitriﬁcans PdTIR [156] showed that they have canonical
TIR-domain folds [67].
TcpB uses the Brucella VirB type-IV secretion system (T4SS)
to gain entry into host cells [154,157,158]. In addition to the C-
terminal TIR domain, TcpB also contains an N-terminal helical
domain reported to bind to phosphoinositides, and it was sug-
gested that TcpB mimics MAL  by binding to lipids in the plasma
membrane and competing with MAL  for binding to MyD88 [151].
By contrast, another study reported that TcpB interacts with MAL
only, and does not compete with MyD88, suggesting it does not
interfere with MAL:MyD88 interactions [152]. This is supported by
Alaidarous and coworkers, who demonstrated that TcpB could pull-
down MAL, MyD88 and TLR4 in co-immunoprecipitation assays,
but only inhibited MAL:TLR4 interactions [148]. A similar mode of
TcpB-mediated interference with MAL:TLR4 interactions was also
proposed by Snyder and coworkers [149]. In addition to its role in
suppressing TLR-mediated immune responses, TcpB also interacts
with microtubules and is able to modulate microtubule dynamics
[159,160].
TcpB exist as a dimer in solution and crystal structures of the
TcpB TIR domain revealed the association mode (Fig. 7A). The BB-
loops, which in MAL  and MyD88 are critical for assembly formation
and NF-B activation, are exposed to the solvent in the dimer
[148–150]. The BB-loop has been shown to be important for TcpB-
mediated suppression of NF-B signaling [148,151]. Decoy peptides
derived from the DD loop of the TcpB TIR domain also inhibit NF-
B activation [161], suggesting that both the BB and DD loops are
involved in signaling-suppression function.
TcpC can permeate the host cell membrane to interact with host
TIR domain-containing proteins and cause immune suppression
[149,154]. Interaction analyses have shown that recombinant puri-
ﬁed TcpC can pull down both TLR4 and MyD88 from HEK293 cell
lysates [153]. Although the crystal structure of the TcpC TIR domain
is not available, pull-down assays using a peptide corresponding to
the predicted TcpC BB loop suggest that the TcpC BB loop interacts
with TLR4, but not MyD88. On the other hand, pull-down assays
with a peptide corresponding to the predicted TcpC DD loop show
interactions with MyD88 but not TLR4, suggesting that TcpC can
target both TLR4 and MyD88 via its BB and DD loops, respectively.
As these loops are also important for TcpB-mediated suppression
of TLR signaling, TcpB and TcpC may  share a common mechanism
for inhibition of TIR:TIR interactions in TLR signaling. In the same
study, NMR  titration experiments revealed that residues in the CD,
DE and EE-loops and the E-strand of the MyD88 TIR domain are
involved in binding to TcpC [153,162]. Mapping of these regions
onto the MyD88 TIR domain assembly model suggests that TcpC
can disrupt both intra- and interstrand MyD88 TIR:TIR interactionsnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
(Fig. 7B) [15]. Interestingly, a recent study showed that TcpC could
also inhibit the NLRP3 inﬂammasome by sequestering both NLRP3
and caspase-1. This resulted in attenuation of caspase-1 process-
ing and activation, IL-1 production and dampening of the innate
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Table  2
Molecular-mimic negative regulators of RLR signaling.
Protein Organism Structure Mechanism of action References
VP35 Ebola virus, Marburg virus Coiled-coil domain, C-terminal
dsRNA-binding domain
Prevention of RIG-I and MDA5
activation
[131–134]
La  Human La motif, RNA recognition motif
(ribonucleoprotein family)
Recruited by respiratory syncitia virus
to viral RNA to prevent RIG-I activation
[135]
V  Measles, Nipah, parainﬂuenza 5 viruses P protein N-terminal module,
zinc-binding domain of
Paramyxoviridae V proteins
Decoy substrate for PP1 to prevent
dephosphorylation of RIG-I and MDA5;
binding to MDA5 to inhibit CARDs
oligomerization
[140]
NS1,  NS2 Respiratory syncitia virus No classiﬁable domains Binding RIG-I and MAVS (preventing
RIG-I:MAVS interaction)
[141,142]
Table 3
Molecular-mimic negative regulators of TLR signaling.
Protein Organism Structure Mechanism of action References
Btp1/BtpA/TcpB Brucella melitensis Tcp Suppression of NF-B by targeting the TLR2
and TLR4-mediated signalosome
[148–151,157,184]
BtpB  Brucella ssp. Tcp Inhibition of MyD88-dependent TLR signaling [158]
TcpC  Uropathogenic
Escherichia coli (UPEC),
strain CFT073
Tcp Suppression of NF-B by targeting TLR2, TLR4
and MyD88; inhibition of NLRP3
inﬂammasome by binding NLRP3 and
caspase-1
[153,155,163,185]
PdTIR  Paracoccus denitriﬁcans Tcp Interactions with MyD88, no evidence for role
in  virulence
[156]
TlpA  Salmonella enterica
serovar Enteritidis
Tcp Suppression of NF-B activation by TLR4,
IL-1R, and MyD88-dependent pathways and
modulation of IL-1 secretion during infection
[186,187]
TirS  Staphylococcus aureus
(MSSA476)
Tcp Suppression of NF-B by targeting TLR2, TLR4,
TLR5, and TLR9-dependent pathways
[187,188]
TcpF  Enterococcus faecalis
V583
Tcp BB-loop mediated interactions with MyD88
and dampening of NF-B activation
[189]
BaTdp Bacillus anthracis Tcp Interaction with MyD88; not an
immune-suppressor, induces autophagy
[190]
YpTdp Yersinia pestis Tcp Interaction with MyD88, downregulation of
IL-1 and LPS-dependent NF-B activation
in-vitro;  it does not show virulence in in-vivo
mouse models
[191,192]
HP1437 Helicobacter pylori Tcp Interaction with MyD88, no evidence for role
in virulence
[193]
PumA Pseudomonas
aeruginosa PA7 strain
Tcp Interaction with MAL, MyD88 and
ubiquitin-associated protein 1 (UBAP1);
[194]
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mmune responses [163,164]. TcpC was also reported to have NAD+
leavage activity [147]. Further structural and biochemical studies
re needed to provide a deﬁnitive mechanism for the virulence of
cpC.
.3.2. Inhibition of TLR signaling by viral proteins
Similar to bacteria, viruses have also evolved immune-evasion
echanisms by interfering with TLR signaling. The vaccinia virus
VACV) proteins A46 and A52 were identiﬁed as anti-inﬂammatory
roteins that inhibit TLR signaling [165]. A46 was  the ﬁrst reported
iral protein that exerts its inhibitory role by interacting with TLR
daptors (MAL, MyD88, TRIF and TRAM) [166,167]. In a more recent
tudy, it was shown that A46 neither interferes with TLR4 dimeriza-
ion nor with the adaptor:adaptor interactions, but rather disrupts
he receptor:adaptor (TLR4:MAL and TLR4:TRAM) interactions, by
argeting their BB-loops [168]. A52 does not interact with host TIR
omains, but instead binds to IRAK2 and TRAF6 [169,170].
Although earlier studies proposed that the C-terminal domain of
46 has a TIR-domain-fold [165,166], more recent studies showed
hat it possesses a Bcl-2-fold consisting of an -helix surroundedPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
y ﬁve or six other -helices [171–175] (Fig. 7C). A46 is therefore
 member of the VACV Bcl-2-fold protein family that includes A49,
52, B14, F1, K7 and N1, although most have functions other than
nhibition of TLR signaling [176].inhibition of NF-B signaling
Disruption of TLR4:MAL and TLR4:TRAM
interactions
[174–176]
A peptide corresponding to the ﬁrst -helix of the A46 Bcl-2
domain (residues 88–98), named VIPER (viral inhibitory peptide of
TLR4), was  found to be crucial for the interactions with the host TIR-
domain proteins (Fig. 7C) [174,175,177]. In this peptide, positively
charged residues were proposed as important for interacting with
the electronegative interfaces of MAL  and TRAM [174,177]. Binding
assays and docking studies conﬁrmed the VIPER peptide binds to
MAL  and TRAM only [174,175].
The structure of the N-terminal domain of A46 bound to a myris-
tic acid molecule shows A46 possesses an unusual lipid-binding
fold, consisting exclusively of -strands (Fig. 7D) [176]. In accor-
dance with previous ﬁndings [175], small-angle X-ray scattering
(SAXS) data showed that full-length A46 forms a tetramer in solu-
tion [176]. In the full-length A46 protein, the N- and C-terminal
domains are linked by a ﬂexible linker, and full-length A46 shows a
higher binding afﬁnity for TLR adaptors in comparison to the N- or
C-terminal domains only. Both the N- and C-terminal domains of
A46 have been shown to interact with the MyD88 TIR domain; thus,
a bipartite mechanism has been proposed, in which full-length A46
wraps around MyD88, so that the DDs of MyD88 cannot interactnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
with other partners of the myddosome complex [176]. It has also
been proposed that the A46 N-terminal myristate binding pocket
may  sequester the myristic acid from TRAM, which is required for
membrane association and formation of the signalosome [81], in
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Fig. 7. Structures of TcpB and A46, and mapping of the TcpC binding sites on MyD88. (A) Symmetric homodimer of the TcpB TIR domain (PDB ID: 4LQC). The BB-loops (red)
are  exposed to the solvent while the DD-loops (blue) are located within the dimer interface. (B) Mapping of the TcpC binding sites onto a model of a MyD88 TIR domain
assembly (based on the cryo-EM structure of the MAL  TIR domain ﬁlament; PDB ID 5UZB). Residues involved in the interaction with TcpC are highlighted in blue on the
MyD88  TIR domain subunit shown in grey surface representation. (C) Cartoon representation of the A46 C-terminal Bcl-2 domain (PDB ID: 4M0S) with the VIPER peptide
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ddition to the A46C-terminal domain binding to the TIR domain of
RAM [176]. Detailed structural analyses of A46:TLR adaptor com-
lexes will be required to elucidate the molecular mechanisms of
isruption of SCAF by viral proteins in TLR pathways.
.4. Inhibition of necroptosis
Inhibition of necroptosis has been reported for only a small num-
er of pathogens. Of those reported, the most well characterized
re two viral RHIM domain-containing molecular mimics, ICP6 and
CP10 from herpes simplex virus (HSV)-1 and HSV-2, respectively.
he N-termini of ICP6 and ICP10 contain a RHIM motif similar to
hat found in RIP1 and RIP3, which facilitates binding to RIP1 and
IP3, as well as disruption of the RIP1 and RIP3 RHIM domain inter-
ctions required for the formation of the necrosome.
Inhibition of necrosome formation, and subsequently necrop-
osis, by ICP6 and ICP10 can be clearly attributed to the RHIM
omains of ICP6 and ICP10. Wild-type ICP6 and ICP10 are able to
uppress RIP3-mediated necroptosis, while RHIM domain trunca-
ions or mutations do not prevent cell death in RIP3-expressingPlease cite this article in press as: J.D. Nanson, et al., Regulation of sig
immunity signalosomes by molecular mimics, Semin Cell Dev Biol (20
uman cell lines [178]. Interestingly, ICP6 and ICP10 also con-
ain a C-terminal ribonucleotide reductase (RR) domain, which
inds to and inhibits caspase-8. Thus ICP6 and ICP10 appear to
isrupt caspase-8-mediated apoptosis, initiate necroptosis, andepresentation of the dimeric A46 N-terminal domain (the two  chains are shown in
subsequently disrupt the formation of the necrosome to simulta-
neously inhibit two cell death pathways [178].
Notably, co-immunoprecipitation experiments in mouse cells
also demonstrated that ICP6 is able to bind both RIP1 and RIP3
[179]. However, in contrast to experiments using human-derived
cell lines in which the interaction of ICP6 and ICP10 with RIP1/3 dis-
rupts the assembly of the necrosome, the association between ICP6
and RIP1/3 in necroptosis-sensitive mouse cell lines nucleates the
assembly of the necrosome and initiates necroptosis, suggesting
that the activities of ICP6 and ICP10 may  be host-speciﬁc [179].
Similarly, the MCMV  (murine cytomegalovirus) genes M36  and
M45 encode the proteins vICA (viral inhibitor of caspase-8 activa-
tion) and vIRA (viral inhibitor of RIP activation), respectively. As the
name suggests, vICA and vIRA are essential for preventing apoptotic
or necroptotic death responses following MCMV infection [180].
Like ICP6 and ICP10, vIRA contains an N-terminal RHIM domain,
which facilities inhibition of necroptosis, as evident by the fact that
vIRA RHIM domain mutants fail to prevent cell death in epithelial
and macrophage cell lines infected with MCMV.  Presumably, the
aim of these viral mimics is to delay or prevent cell death responsesnaling by cooperative assembly formation in mammalian innate
18), https://doi.org/10.1016/j.semcdb.2018.05.002
allowing the generation of viral progeny. In this context, it is not
surprising that MCMV-containing defective vIRA RHIM mutations
induce rapid cell death upon infection, resulting in reduced viral
yields following infection [180].
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. Conclusions
SCAF is emerging as an important signaling mechanism in innate
mmunity pathways [1–6,19,20]. Importantly, while the character-
zed examples have largely involved members of the death-fold
amily, the TIR domain has recently been established as another
tructural motif ubiquitous in innate immunity pathways that
orms open-ended assemblies and engages in SCAF [15]. Interest-
ngly, TIR domains can themselves possess enzymatic activity [181],
uggesting they can fulﬁl the function of both adaptors and effector
nzymes at the same time.
The cooperative nature of SCAF can be compared to assembly by
rions and amyloids [19]. Indeed, a yeast prion domain has been
hown to be able to functionally replace PYDs in mammalian cell
ignaling [182]. However, SCAF is a more inclusive term, as it does
ot imply irreversible conformational changes usually associated
ith prion and amyloid assemblies. Structurally, some assemblies
iscussed in this review (e.g. the RHIM-mediated ones) resemble
myloids and prions more closely, while many others are medi-
ted by folded domains and the cooperativity may  rely more on
xtended binding surfaces than conformational changes. At least
ome innate immunity signalosomes can disassemble, presumably
s a mechanism of regulation or signal termination, for example
yddosomes [78] and NLRP3 inﬂammasomes [183].
One way to regulate SCAF is through proteins that mimic  assem-
ly components and act as decoys, inhibiting the regular assembly
rocess by either capping the open-ended complexes or incor-
orating into the assemblies and interfering in other ways with
he normal signaling process. While the exact mechanisms remain
nknown for most cases, evidence suggests the molecular mecha-
isms of inhibition of inﬂammasome signaling by INCA and MC159
nvolve ﬁlament capping to prevent activation of effector enzymes,
hile ICEBERG and cFLIP incorporate into signaling assemblies
nd presumably interfere with proximity-based activation of effec-
or enzymes [13,43]. For pathogens, the ability to modulate host
mmune responses via molecular mimics and prevent clearing of
nfection has obvious implications for pathogen survival. However,
hy the genomes of higher organisms such as humans encode a
iverse array of COPs and POPs is less clear. There is certainly a
eed to regulate innate immunity pathways, with aberrant signal-
ng observed in many disorders associated with these pathways.
nhibition of aberrant signaling either by directly inhibiting signal-
ng or by reducing the local concentration of effector proteins below
 signaling threshold, appears to be the predominant role of these
olecular mimics. However, mimics such as COP1 and ICEBERG,
hich have less deﬁned roles in signaling, may  modulate signaling
o provide a controlled and sustained release of pro-inﬂammatory
actors over time. Similarly, necroptosis has been theorized to
rovide a mechanism in which DAMPs are released in order to pro-
oke immune responses to clear infection. As more examples of
CAF modulation are characterized, we expect that new regulatory
echanisms and new variants of documented mechanisms will be
ncovered.
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